Quarterly report pursuant to Section 13 or 15(d)

STOCK BASED COMPENSATION

v3.24.3
STOCK BASED COMPENSATION
9 Months Ended
Sep. 30, 2024
STOCK BASED COMPENSATION  
STOCK BASED COMPENSATION

20. STOCK BASED COMPENSATION

The 2020 Incentive Award Plan (the “2020 Plan”) allows for the award of incentive and nonqualified stock options, restricted stock, and other stock-based awards to employees, officers, directors, consultants, and advisers of the Company. As of December 31, 2023, the number of shares available for future issuance is 2,821,050 under the 2020 Plan. In addition, the number of shares of common stock available for issuance under the 2020 Plan is subject to an annual increase on the first day of each calendar year beginning on January 1, 2021 and ending on and including January 1, 2030 equal to the lesser of (i) 5% of the aggregate number of shares of common stock outstanding on the final day of the immediately preceding calendar year and (ii) such smaller number of shares as is determined by the Board of Directors. On January 1, 2024, 1,626,358 shares were added as available for issuance to the 2020 Plan.

Stock Options

The option activity of the Plans for the nine months ended September 30, 2024, is as follows (shares in thousands):

    

    

Weighted-Average 

 

Weighted-Average 

Remaining 

 

Aggregate

Number of 

Exercise Price 

Contractual Term 

 

Intrinsic Value

    

Shares

    

per Share

    

(in years)

 

(in thousands)

Outstanding at January 1, 2024

616

$

18.30

 

4.97

$

140

Forfeited/expired

 

(59)

$

16.76

Outstanding at September 30, 2024

 

557

$

18.50

4.19

70

Options vested at September 30, 2024

 

557

$

18.50

4.19

70

Options vested or expected to vest at September 30, 2024

 

557

$

18.50

4.19

70

There were no options exercised during the three and nine months ended September 30, 2024, as such, there is no aggregate intrinsic value of options exercised during the three and nine months ended September 30, 2024. The aggregate intrinsic value of options exercised during the nine months ended September 30, 2023 was $0.9 million.

The total stock-based compensation expense related to stock options was $0.1 and $0.7 million during the three and nine months ended September 30, 2024, respectively, and $0.3 million and $1.0 million during the three and nine months ended September 30, 2023, respectively. At September 30, 2024, the stock options were fully vested.

Restricted Stock Awards

In connection with acquisitions, the Company has granted restricted stock awards (“RSAs”) that are considered post-combination expense and accounted for as stock-based compensation as the shares vest.

There was an immaterial amount of stock-based compensation expense related to RSAs during the three and nine months ended September 30, 2024 and $0.1 million and $0.7 million during the three and nine months ended September 30, 2023, respectively. At September 30, 2024, the RSAs were fully vested.

Restricted Stock Units

Restricted Stock Units (“RSUs”) awarded to employees and non-employees generally vest over four years from the anniversary date of the grant, with one-year cliff vesting and quarterly vesting thereafter, provided service with the Company is not terminated. The fair value of RSUs is equal to the estimated fair market value of the Company’s Common Stock on the date of grant.

RSU activity under the 2020 Plan for the nine months ended September 30, 2024, is as follows (shares in thousands):

Shares Subject 

    

Weighted-Average

    

to Vesting

    

Grant Date Fair Value

Balance of unvested shares as of January 1, 2024

2,305

$ 28.44

Granted

1,497

$ 6.73

Vested

(847)

$ 23.65

Cancelled/Forfeited

(256)

$ 32.01

Balance of unvested shares as of September 30, 2024

2,699

The total stock-based compensation expense related to RSUs was $5.6 million and $19.4 million during the three and nine months ended September 30, 2024, and $7.3 million and $25.0 million during the three and nine months ended September 30, 2023. Total unrecognized compensation costs related to unvested RSUs at September 30, 2024 is $30.2 million and is expected to be recognized over a period of 2.1 years.

RSUs include awards that vest subject to certain performance and market-based criteria.

Performance-Based Restricted Stock Units (included above)

During the year ended December 31, 2021, 67,000 performance-based RSUs were granted to key employees of the Company. These awards vest upon the achievement of certain performance milestones by the Company and prescribed service milestones by the employee. During the three and nine months ended September 30, 2024, no performance-based RSUs vested or were forfeited. As of September 30, 2024, 15,000 performance-based RSUs remain outstanding.

During the year ended December 31, 2020, 12,430 performance-based RSUs were granted to a key employee of the Company. This award vests upon the achievement of certain performance milestones by the Company and prescribed service milestones by the employee. During the year ended December 31, 2023, 12,430 performance-based RSUs were forfeited. As of December 31, 2023, no performance-based RSUs remain outstanding.

Market-Based Restricted Stock Units (included above)

In October 2021 the Compensation Committee of the Company’s Board of Directors awarded certain executive officers a total of up to 907,026 market-based RSUs. These RSUs will vest and result in the issuance of shares of Common Stock based on continuing employment and the achievement of certain market conditions set by the Company.

During the year ended December 31, 2021, one of the executive officers resigned from the Company, forfeiting his market-based RSUs. As the service condition was not met prior to his resignation, no stock-based compensation expense was recorded for this award. No market-based RSUs vested or were forfeited during the year ended December 31, 2023 or during the three and nine months ended September 30, 2024. As of September 30, 2024, 680,270 market-based RSUs remain outstanding.

Bonus Program

The Company’s bonus program allows the bonus to be paid out in RSUs, cash, or a combination.

The Company’s 2023 bonus program ("2023 Bonus Program") was granted in dollar bonus amounts, which were paid out in RSUs during the three months ended March 31, 2024. The number of RSUs awarded was determined using the closing price of the Company's Common Stock on the date of the Board's final certification of the Company's performance attainment and awards to be issued to each employee. The Company accounted for these awards as liability-based awards until the awards were achieved, at which point the Company accounted for these awards as equity-based awards. During the three and nine months ended September 30, 2023, the Company recognized $(0.7) and $2.2 million of stock-based compensation expense associated with liability classified awards related to the 2023 Bonus Program.

The Company’s 2024 bonus program (“2024 Bonus Program”) is expected to be paid out in RSUs determined using the closing price of the Company's Common Stock on the date of the Board's final certification of the Company's performance attainment and awards to be issued to each employee. The Company has accounted for these awards as liability-based awards, since the monetary value of the obligation associated with the award is based predominantly on a fixed monetary amount known at inception, and it has an unconditional obligation that it must or may settle by issuing a variable number of its equity shares. The Company will recognize stock-based compensation expense over the employees’ requisite service period, based on the expected attainment of the Company-wide targets. As of September 30, 2024, the Company has accrued $0.5 million associated with these awards, which is recorded in accrued expenses and other current liabilities in the condensed consolidated balance sheets.

Stock-Based Compensation Expense

Total stock-based compensation expense related to all of the Company’s stock-based awards granted is reported in the condensed consolidated statements of operations as follows (in thousands):

Three Months Ended September 30, 

Nine Months Ended September 30, 

2024

    

2023

    

2024

    

2023

Research and development

$

1,896

$

3,662

$

7,783

$

12,612

General and administrative expense

 

2,837

 

2,802

 

9,122

 

10,419

Sales and marketing expense

 

527

 

702

 

1,647

 

1,881

Cost of sales

 

459

 

517

 

1,502

 

1,787

Total stock-based compensation expense

$

5,719

$

7,683

$

20,054

$

26,699

There were 3,249,055 shares available for award under the 2020 Plan at September 30, 2024.